BST 236, A NOVEL CYTARABINE PRO-DRUG ALLOW, FOR THE FIRST TIME, THE DELIVERY OF HIGH CYTARABINE DOSES FOR OLDER OR UNFIT PATIENTS WITH ACUTE LEUKEMIA. RESULTS OF AN ONGOING PHASE I/IIA STUDY-MedSci.cn

BST 236, A NOVEL CYTARABINE PRO-DRUG ALLOW, FOR THE FIRST TIME, THE DELIVERY OF HIGH CYTARABINE DOSES FOR OLDER OR UNFIT PATIENTS WITH ACUTE LEUKEMIA. RESULTS OF AN ONGOING PHASE I/IIA STUDY

Zuckerman, T; Gengrinovitch, S; Ram, R; Flaishon, L; Ben Yakar, R; Hoffman, R; Henig, I; Lavi, N; Akria, L; Ofran, Y; Horowitz, NA; Nudelman, O; Koren-Michowitz, M; Yeganeh, S; Rowe, JM

HAEMATOLOGICA, 2017; 102 ( ): 210

科室
- - 订阅+
  - 更多科室
工具
服务